Yale Ventures

Funds Yale-affiliated research teams through licensing, entrepreneurship support, and commercialization pathways at a university technology hub.

Yale Ventures is Yale University's central innovation and technology-transfer arm, launched in April 2022 and governed by a board of advisors formed in March 2024. Based in New Haven, it manages IP licensing, startup support, and corporate engagement, and it awards about $6 million in translational funding each year.

Its internal funds are limited to Yale faculty and students. The portfolio includes the Blavatnik Fund for Innovation at Yale, which supports life-sciences commercialization with awards up to $300,000; the Roberts Innovation Fund, which supports Yale Engineering projects with awards up to $150,000; and smaller vehicles such as the Rothberg Build Fund, alongside Colton Center for Autoimmunity, HealthTech Works, and the Planetary Solutions Impact Accelerator. The broader platform has generated more than 2,400 Yale patents, 200+ faculty-led spinouts, and about $6 billion in venture funding raised by spinouts over seven years.

Yale Ventures is best suited to internal teams that need translational capital, mentorship, market research, and investor exposure rather than an external competition. Its emphasis is on moving Yale research toward market, clinic, or company formation through a mix of grant funding, training, and commercialization support.